CD73-IN-9
CD73-IN-9 is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-9 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 2) [1].
Product Specifications
CAS Number
2766565-88-0
UNSPSC
12352005
Target
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cd73-in-9.html
Solubility
10 mM in DMSO
Smiles
O=C1NC=C(C(N1)=O)C2=NN3C=NC=C3C([C@H]4C[C@@H]4C(F)F)=C2
Molecular Formula
C14H11F2N5O2
Molecular Weight
319.27
References & Citations
[1]Xuejun Zhang, et al. Pyrimidinedione compound and use thereof. Patent WO2022068929A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CCR5 (Chemokine (C-C motif) Receptor 5, C-C Chemokine Receptor Type 5, CCCKR5, CC-CKR-5, C-C CKR-5, CCR-5, AM4-7, CD195, CHEMR13, CKR5, CMKBR5, FLJ78003, HIV-1 Fusion Coreceptor, IDDM22) (MaxLight 405) discontinued
Lentiviral mouse Fbxl2 shRNA (UAS) - Lentiviral mouse Fbxl2 shRNA (UAS, GFP) (100)
NET5 (Transmembrane Protein 201, Spindle-associated Membrane Protein 1, TMEM201, SAMP1) (HRP)